Search Results 61-70 of 17080 for ibs
This longitudinal study is being done to understand mechanisms underlying development of irritable bowel syndrome (IBS) and the role of the gut bacteria in ...
Research. Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. Researchers in the Enteric ...
About this study. Microbiota from fecal samples from IBS-D patients, in combination with vitamin D supplementation added to our 3-D immunocompetent ...
About this study. The purpose of this study is to measure 48 hour fecal bile acids in IBS-D adolescents and compare it to HC; measure serum C4 and FGF-19 in ...
IBS is a chronic condition charac- terized by abdominal pain that occurs before or along with diarrhea or con- stipation. The diarrhea or constipation can ...
difficile disease (rCDI) and using a combination of clinical and laboratory markers to determine disease versus post infectious irritable bowel syndrome (IBS) ...
Eluxadoline has been approved by the FDA for people with IBS-D but it is not known whether it will work the same way in people with IBS-D who also have BAM.
Studies have demonstrated that BAM occurs in about one-third of patients diagnosed with irritable bowel syndrome with diarrhea (IBS ... IBS-D. A clinical ...
Linaclotide is used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It works by increasing intestinal ...
Bile Acids, Genetic Control and Ileo-Colonic Mucosal Expression in IBS-D · More about research at Mayo Clinic · Mayo Clinic Footer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.